Financials

688217 fundamentals

An in-depth look to SHANGHAI RIGHTONGENE BIOTECHNOLOGY operating, investing, and financing activities

688217 free cash flow for Q1 25 is 9.59 M CNY. For 2024, 688217 free cash flow was 22.56 M CNY and operating cash flow was 61.97 M CNY.

Q3 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Cash from operating activities

Cash from investing activities

Cash from financing activities

Currency: CNY